A synthetic peptide derived from the external glycoprotein of human T cell lymphotropic virus type I (HTLV-I) (Env-5; amino acids 242 to 256) reacted with IgG antibodies in serum specimens from HTLV-I-infected individuals. C-terminal residues of Env-5 were crucial for the antibody reactivity. Polyclonal rabbit antibodies to Env-5 did not inhibit syncytium formation but such antibodies reacted specifically with gp68env and gp46env glycoproteins of HTLV-I in an immunoblot analysis. Immunoprecipitation of the surface-labelled MT-2 (HTLV-I-infected) cell line with anti-Env-5 precipitated the gp68env precursor protein. It was concluded that peptide Env-5 mimics a surface-exposed epitope on the HTLV-I external glycoprotein.
ClaphamP.,
NagyK.,
WeissR. A.1984; Pseudotypes of human T-cell leukemia virus type 1 and 2: neutralization by patients’ sera. Proceedings of the National Academy of Sciences, U.S.A. 81:2886–2889
HoralP.,
JeanssonS.,
RymoL.,
SvennerholmB.,
VahlneA.1990; Epitope profiles of HTLV-I env and gag gene encoded proteins. In Human Retrovirology: HTLV pp 461–467 Edited by
BlattnerW. A.
New York: Plenum Press;
HoshinoH.,
ShimoyamaM.,
MiwaM.,
SugimuraT.1983; Detection of lymphocytes producing a human retrovirus associated with adult T-cell leukemia by syncytium induction assay. Proceedings of the National Academy of Sciences, U.S.A 80:7337–7341
JacobsonS.,
ReubenJ.,
StreileinR.,
PalkerT. J.1991; Induction of CD4+, HTLV-I specific cytotoxic T lymphocytes from patient with HAM/TSP: recognition of an immunogenic region of the gp46 envelope glycoprotein of HTLV-I. Journal of Immunology 146:1155–1162
KurataA.,
PalkerT. J.,
StreileinR. D.,
ScearceR. M.,
HaynesB. F.,
BerzofskyJ. A.1989; Immunodominant sites of human T cell lymphotropic virus type 1 envelope protein for murine helper T cells. Journal of Immunology 143:2024–2030
KurodaN.,
WashitaniY.,
ShirakiH.,
KiyokawaH.,
OhnoM.,
SatoH.,
MaedaY.1990; Detection of antibodies to human T-lymphotropic virus type I by using synthetic peptides. International Journal of Cancer 45:865–868
LalR. B.1991; Structural similarity of envelope glycoprotein of HTLV-I and C-terminal region of v-erbB and EGF receptor. AIDS Research and Human Retroviruses 7:459–460
LalR. B.,
RudolphD. L.,
LairmoreM. D.,
KhabbazR. F.,
GarfieldM.,
ColiganJ. E.,
FolksT. M.1991a; Serologic discrimination of HTLV-I and HTLV-II infection by using a synthetic peptide based enzyme immunoassay. Journal of Infectious Diseases 163:41–46
LalR. B.,
RudolphD. L.,
GrifficK. P.,
KitamuraK.,
HondaM.,
ColiganJ. E.,
FolksT. M.1991b; Characterization of immunodominant epitopes of gag and pol gene encoded proteins of human T lymphotropic virus type-I. Journal of Virology 65:1870–1876
LernerR. A.,
ChanockR. M.1984; Modern Approaches to Vaccines: Molecular and Chemical Basis of Virus Virulence and Immunogenicity. New York: Cold Spring Harbor Laboratory;
LernerR. A.,
GreenN.,
AlexanderH.,
LiuF. T.,
SutcliffeJ. G.,
ShinnickT. M.1981; Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicits antibodies reactive with the native envelope protein of Dane particles. Proceedings of the National Academy of Sciences, U.S.A 78:3403–3407
PalkerT. J.,
ScearceR. M.,
CopelandT. D.,
OroszlanS.,
HaynesB. F.1986; C-terminal region of human T-cell lymphotropic virus type I (HTLV-I)pl9 core protein is immunogenic in human and contains an HTLV-I specific epitope. Journal of Immunology 136:2393–2397
PalkerT. J.,
TannerM. E.,
ScearceR. M.,
StreileinR. D.,
ClarkM. E.,
HaynesB. F.1989; Mapping of immunogenic regions of human T-cell leukemia virus type-1 (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46. Journal of Immunology 142:971–978
RalstonS.,
HoeprichP.,
AketaR.1989; Identification and synthesis of the epitope for a human monoclonal antibody which can neutralize human T-cell leukemia/lymphotropic virus type I. Journal of Biological Chemistry 264:16343–16346
RueggC. L.,
MonellC. R.,
StrandM.1989; Identification using synthetic peptides of the minimum amino acid sequence from the retroviral transmembrane protein pl5E required for inhibition of lymphoproliferation and its similarity to gp21 of human T-lymphotropic virus types I and II. Journal of Virology 63:3250–3256
SeikiM.,
HattoriS.,
HirayamaR.,
YoshidaM.1983; Human adult T-cell leukemia virus complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proceedings of the National Academy of Sciences, U.S.A 80:3618–3622